23 diciembre 2014
Whole-genome sequencing can be used to identify patients’ risk for hereditary cancer, researchers have demonstrated. This is the first study that has used whole-genome sequencing to evaluate a series of 258 cancer patients’ genomes to improve the ability to diagnose cancer-predisposing mutations, researchers say.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/v4P2cqBAeJY/141223141606.htm
